Bioprinting is the process of producing biomedical items using 3D printing technology that mimics natural tissue.
This is according to Wikipedia’s definition.
It will be a game-changer in the treatment of tumours, according to researchers in Tel Aviv, Israel.
And why is this?
A question with an amazingly quick fix.
By Using “extracts” from the brain of a patient with glioblastoma-
Professor Ronit Satchi-Fainaro, the program’s director, explained that they took a type of cancer with a fatal diagnosis and used that to print a model that matched their MRI images.
Next, the patient’s blood is pumped with the printed tumour,
Made with materials simulating the brain, followed by remedial treatment
Bioprinting and Medicine “Hand in Hand”
While Studies have used bioprinting to mimic tumours, Tel-Aviv Researchers say they are the first to print a working tumour.
The patient’s therapy is viewed favourably if the printed cyst shrinks or has reduced metabolism against other control groups.
Affecting majorly adults, Glioblastoma is a common form of cancer.
And according to the American Association of Neurological Surgeons,
The survival is 40% rate with early detection and 17% in the second year.
A point of note is the use case of 3d printing on cancer cases has always been common,
Recently there is more focus on bioprinting, which uses live cells as a model to build layers.
By, using a patient’s live cells to imitate cancer growth and the tumour is a gamechanger.
Furthermore, The closer it is to a live model-the better the insight on how the drug therapy would work on the patient.
Source: Times of Israel, Sciencedaily